Anifrolumab: Solution concentrate for I.V. infusion 300 mg in 2 mL; Saphnelo® Page last updated: 5 July 2024 Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 1.9MB) Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 1.2MB)